VM (nerve agent)

From WikiMD's WELLNESSPEDIA

Skeletal structure of VM nerve agent

VM is a nerve agent belonging to the V-series nerve agents, which are a group of highly toxic chemical warfare agents. These agents are known for their ability to disrupt the normal functioning of the nervous system by inhibiting the enzyme acetylcholinesterase.

Chemical Structure and Properties[edit]

VM is an organophosphorus compound, characterized by its phosphorus-sulfur bond. The skeletal structure of VM is depicted in the image to the right. Like other V-series agents, VM is a liquid at room temperature and is known for its high boiling point and low volatility, making it a persistent threat in contaminated environments.

Mechanism of Action[edit]

VM, like other nerve agents, exerts its toxic effects by inhibiting the enzyme acetylcholinesterase. This enzyme is crucial for the breakdown of the neurotransmitter acetylcholine in the synaptic cleft. When acetylcholinesterase is inhibited, acetylcholine accumulates, leading to continuous stimulation of muscles, glands, and central nervous system structures. This results in a range of symptoms, including muscle twitching, respiratory failure, and potentially death.

Symptoms of Exposure[edit]

Exposure to VM can lead to a variety of symptoms, depending on the dose and route of exposure. Common symptoms include:

Treatment[edit]

The primary treatment for VM exposure involves the administration of atropine and pralidoxime. Atropine works by blocking the effects of acetylcholine at muscarinic receptors, while pralidoxime reactivates acetylcholinesterase by removing the phosphate group attached by the nerve agent. Supportive care, including ventilation and oxygen therapy, may also be necessary.

History and Use[edit]

The V-series nerve agents, including VM, were developed during the Cold War as part of chemical weapons programs. Due to their high toxicity and persistence, these agents are considered weapons of mass destruction and are banned under the Chemical Weapons Convention.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.